Pfizer continues progress on COVID-19 vaccine
Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the...
A drug being developed by New Haven’s Kleo Pharmaceuticals to treat the blood cancer multiple myeloma has been granted “orphan” status by the FDA. The...
Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the...
Women In Bio has launched an Executive Women In Bio (EWIB) cohort in Connecticut. This group was co-founded by Rebecca Velez Frey Pharm.D., COO EvolveImmune Therapeutics...
Yale’s wastewater sampling project – an effort to predict outbreaks of COVID-19 in communities – has expanded to several locations in Connecticut. Yale researchers have...
A med-tech company based in Bethany CT has won a federal grant to advance the development of a device that aims to improve treatment options...
The University of Connecticut will launch a new internal funding program to support researchers at all of UConn’s campuses who are using their expertise to...
The Office of Cooperative Research at Yale University has announced that the FDA has granted “Safe to Proceed” notices to two separate Investigational New Drug...
A Woodbridge, CT bioscience company said it has developed a product that can act as an on/off switch for certain immunotherapy treatments, raising hopes that...
Researchers at UConn Health and CaroGen, a biopharmaceutical company based at UConn’s Technology Incubation Program (TIP) facility in Farmington, have developed a promising clinical candidate...